These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18046488)

  • 1. The effect of Tookad-mediated photodynamic ablation of the prostate gland on adjacent tissues--in vivo study in a canine model.
    Huang Z; Chen Q; Dole KC; Barqawi AB; Chen YK; Blanc D; Wilson BC; Hetzel FW
    Photochem Photobiol Sci; 2007 Dec; 6(12):1318-24. PubMed ID: 18046488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation.
    Huang Z; Chen Q; Trncic N; LaRue SM; Brun PH; Wilson BC; Shapiro H; Hetzel FW
    Radiat Res; 2004 Jun; 161(6):723-31. PubMed ID: 15161347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of a vascular-acting photosensitizer, Pd-bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer.
    Huang Z; Chen Q; Luck D; Beckers J; Wilson BC; Trncic N; Larue SM; Blanc D; Hetzel FW
    Lasers Surg Med; 2005 Jun; 36(5):390-7. PubMed ID: 15856509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers.
    Chen Q; Huang Z; Luck D; Beckers J; Brun PH; Wilson BC; Scherz A; Salomon Y; Hetzel FW
    Photochem Photobiol; 2002 Oct; 76(4):438-45. PubMed ID: 12405153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging correlated with the histopathological effect of Pd-bacteriopheophorbide (Tookad) photodynamic therapy on the normal canine prostate gland.
    Huang Z; Haider MA; Kraft S; Chen Q; Blanc D; Wilson BC; Hetzel FW
    Lasers Surg Med; 2006 Aug; 38(7):672-81. PubMed ID: 16799982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of photodynamic therapy on peripheral nerve: in situ compound-action potentials study in a canine model.
    Dole KC; Chen Q; Hetzel FW; Whalen LR; Blanc D; Huang Z
    Photomed Laser Surg; 2005 Apr; 23(2):172-6. PubMed ID: 15910181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts.
    Koudinova NV; Pinthus JH; Brandis A; Brenner O; Bendel P; Ramon J; Eshhar Z; Scherz A; Salomon Y
    Int J Cancer; 2003 May; 104(6):782-9. PubMed ID: 12640688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy in the canine prostate using motexafin lutetium.
    Hsi RA; Kapatkin A; Strandberg J; Zhu T; Vulcan T; Solonenko M; Rodriguez C; Chang J; Saunders M; Mason N; Hahn S
    Clin Cancer Res; 2001 Mar; 7(3):651-60. PubMed ID: 11297261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic vascular targeted photodynamic therapy with the photosensitizer WST11 for benign prostatic hyperplasia in the preclinical dog model.
    Chevalier S; Cury FL; Scarlata E; El-Zayat E; Hamel L; Rocha J; Zouanat FZ; Moussa S; Scherz A; Elhilali M; Anidjar M
    J Urol; 2013 Nov; 190(5):1946-53. PubMed ID: 23680311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: a biphasic apparent diffusion coefficient change as potential early MRI response marker.
    Plaks V; Koudinova N; Nevo U; Pinthus JH; Kanety H; Eshhar Z; Ramon J; Scherz A; Neeman M; Salomon Y
    Neoplasia; 2004; 6(3):224-33. PubMed ID: 15153334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser dosimetry studies in the prostate.
    Chen Q; Hetzel FW
    J Clin Laser Med Surg; 1998 Feb; 16(1):9-12. PubMed ID: 9728124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the photosensitizer Tookad for photodynamic therapy on the Syrian golden hamster cheek pouch model: light dose, drug dose and drug-light interval effects.
    Borle F; Radu A; Monnier P; van den Bergh H; Wagnières G
    Photochem Photobiol; 2003 Oct; 78(4):377-83. PubMed ID: 14626666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of cutaneous photosensitivity of TOOKAD (WST09) in preclinical animal models and in patients.
    Weersink RA; Forbes J; Bisland S; Trachtenberg J; Elhilali M; Brún PH; Wilson BC
    Photochem Photobiol; 2005; 81(1):106-13. PubMed ID: 15382963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial distribution of liposome encapsulated tin etiopurpurin dichloride (SnET2) in the canine prostate: implications for computer simulation of photodynamic therapy.
    Aniola J; Selman SH; Lilge L; Keck R; Jankun J
    Int J Mol Med; 2003 Mar; 11(3):287-91. PubMed ID: 12579328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response.
    Trachtenberg J; Bogaards A; Weersink RA; Haider MA; Evans A; McCluskey SA; Scherz A; Gertner MR; Yue C; Appu S; Aprikian A; Savard J; Wilson BC; Elhilali M
    J Urol; 2007 Nov; 178(5):1974-9; discussion 1979. PubMed ID: 17869307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of tin ethyl etiopurpurin photodynamic therapy of the canine prostate.
    Selman SH; Albrecht D; Keck RW; Brennan P; Kondo S
    J Urol; 2001 May; 165(5):1795-801. PubMed ID: 11342978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial photodynamic therapy in the canine prostate.
    Lee LK; Whitehurst C; Chen Q; Pantelides ML; Hetzel FW; Moore JV
    Br J Urol; 1997 Dec; 80(6):898-902. PubMed ID: 9439405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer.
    Azzouzi AR; Barret E; Moore CM; Villers A; Allen C; Scherz A; Muir G; de Wildt M; Barber NJ; Lebdai S; Emberton M
    BJU Int; 2013 Oct; 112(6):766-74. PubMed ID: 24028764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectivity of the photosensitiser Tookad for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour model.
    Borle F; Radu A; Fontolliet C; van den Bergh H; Monnier P; Wagnières G
    Br J Cancer; 2003 Dec; 89(12):2320-6. PubMed ID: 14676813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipophilic photosensitizer administration via the prostate arteries for photodynamic therapy of the canine prostate.
    Xiao Z; Owen RJ; Liu W; Tulip J; Brown K; Woo T; Moore RB
    Photodiagnosis Photodyn Ther; 2010 Jun; 7(2):106-14. PubMed ID: 20510305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.